Shield Therapeutics plc Reports Earnings Results for the Half Year Ended June 30, 2021
August 17, 2021 at 02:00 am EDT
Shield Therapeutics plc announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was GBP 481,000 compared to GBP 8.919 million a year ago. Operating loss was GBP 7.643 million compared to operating Income of GBP 2.393 million a year ago. Net loss was GBP 7.283 million compared to net income of GBP 3.124 million a year ago. Basic loss per share from continuing operations was GBP 0.04 compared to basic earnings per share from continuing operations of GBP 0.03 a year ago.